FDA Inspection 1166215 — Reproductive Science Center of New Jersey, P.A.
The FDA completed an inspection of Reproductive Science Center of New Jersey, P.A. on March 29, 2022 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Eatontown, NJ (United States)